BIO-key International, Inc. (NASDAQ: BKYI) is a company at the forefront of the biometric technology field. It provides cutting-edge fingerprint identification and identity management solutions designed to secure workforces and networks. While BIO-key International offers innovative products, its financial efficiency is currently under review. A key way to measure this investment analysis is by comparing its returns to its costs.
To understand a company's financial health, we can look at two critical profitability metrics. Return on Invested Capital (ROIC) shows how much profit a company makes from its investments. Weighted Average Cost of Capital (WACC) is the average cost the company pays for its funding, reflecting its capital structure. A healthy company typically has an ROIC higher than its WACC.
BIO-key International currently shows a significant financial challenge. Its ROIC is -49.59%, meaning it is not generating a positive return on its capital. This is much lower than its WACC of 16.16%. This difference indicates that for every dollar BIO-key International invests, it is currently losing shareholder value.
When compared to its peers, the entire group shows difficulty with profitability. All competitors in this analysis, including Sintx Technologies and Boxlight Corporation, have an ROIC lower than their WACC. This suggests a challenging sector performance and competitive landscape, where generating returns is proving difficult across the board for these specific companies, reflecting current market trends.
Among its peers, SuperCom Ltd. (NASDAQ: SPCB) performs the best in this specific comparison. SuperCom has an ROIC of -1.89% and a WACC of 10.14%. While its investment returns are still negative, it is the closest to breaking even. This makes SuperCom the most capital-efficient company in this group, as it is destroying the least amount of value.
